International Journal of Clinical Case Reports 2024, Vol.14, No.5, 290-298 http://medscipublisher.com/index.php/ijccr 293 presenting with pain and difficulty swallowing, and may result in weight loss due to reduced oral intake. Late toxicities include pulmonary fibrosis, which can impair respiratory function long after treatment. Additionally, cardiac toxicities, such as radiation-induced heart disease (RIHD), have been observed, especially with higher doses to the heart during thoracic radiotherapy (Kang et al., 2015; Ming et al., 2016). 5.2 Management of acute and late toxicities The management of acute toxicities primarily involves symptomatic relief. For radiation pneumonitis, corticosteroids are commonly used to reduce inflammation, while oxygen therapy and bronchodilators can provide respiratory support. Esophagitis is managed with analgesics, acid suppression, and diet modifications to reduce discomfort. Long-term toxicities, such as pulmonary fibrosis, are managed through supportive care including pulmonary rehabilitation and supplemental oxygen. Cardiac toxicity is monitored with regular cardiac function assessments, and management strategies focus on minimizing further damage and addressing cardiovascular risk factors (Baker and Fairchild, 2016; Käsmann et al., 2020). 5.3 Strategies to minimize radiotherapy-related complications Advancements in radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT), have helped to reduce the dose delivered to healthy tissues, minimizing toxicities. Using advanced imaging for treatment planning also allows for more precise targeting of the tumor while sparing surrounding organs. To minimize cardiac toxicity, it is essential to limit the dose to the heart by employing techniques such as proton therapy or gating methods to account for tumor motion. Additionally, the use of genetic biomarkers to predict individual susceptibility to radiotherapy-induced toxicities holds promise for personalizing treatment and further reducing complications (Bourbonne et al., 2020; Vojtíšek et al., 2020). 6 Technological Innovations in Radiotherapy Delivery 6.1 Real-time tumor tracking and adaptive radiotherapy Real-time tumor tracking is a critical innovation in radiotherapy, particularly for lung cancer patients where respiratory motion poses a significant challenge. This technology allows continuous monitoring of tumor movement, adjusting the radiation beam accordingly to ensure accurate targeting of the tumor while minimizing radiation to surrounding healthy tissues. One method involves magnetic resonance-guided radiotherapy (MRgRT), which offers superior soft-tissue contrast for tumor visualization and allows online adaptive radiotherapy based on real-time imaging during treatment. Real-time tumor tracking systems such as U-Net-based models for 4D CT imaging have shown potential to further refine adaptive radiotherapy by improving motion management and tracking (Kronemeijer et al., 2022). These advancements reduce the risk of overexposing healthy tissues to radiation, improving both treatment precision and patient outcomes (Thorwarth and Low, 2021). 6.2 Image-guided radiotherapy (IGRT) Image-Guided Radiotherapy (IGRT) has revolutionized radiotherapy delivery by integrating imaging techniques to localize the tumor before and during treatment. IGRT improves accuracy by adjusting radiation delivery based on real-time images of the tumor and surrounding anatomy. Recent developments have seen the use of machine learning and artificial intelligence (AI) to enhance IGRT systems by automating image processing tasks such as tumor localization, motion prediction, and adaptive treatment adjustments. These innovations allow for more precise dose delivery and reduce treatment uncertainty, particularly for tumors that move during treatment, such as in lung cancer. AI-based approaches, including deep learning models, have further improved image denoising and real-time image processing, enabling clinicians to make faster and more accurate adjustments during treatment (Mori, 2017). 6.3 Artificial intelligence and machine learning in radiotherapy planning Artificial intelligence (AI) and machine learning (ML) are rapidly transforming radiotherapy planning, offering significant improvements in treatment precision, efficiency, and adaptability. AI algorithms are being used to automate tasks such as treatment plan optimization, tumor segmentation, and dose prediction, which traditionally relied on manual intervention. AI enhances the accuracy of these processes while reducing time and potential
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==